BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30478763)

  • 1. Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.
    Okita K; Hatakeyama S; Fujita N; Konishi S; Yamamoto H; Imai A; Yoneyama T; Hashimoto Y; Ito H; Yoshikawa K; Koie T; Ohyama C
    Med Oncol; 2018 Nov; 36(1):7. PubMed ID: 30478763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
    Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
    Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
    Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A;
    BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of robot-assisted vs. open radical cystectomy.
    Hanna N; Leow JJ; Sun M; Friedlander DF; Seisen T; Abdollah F; Lipsitz SR; Menon M; Kibel AS; Bellmunt J; Choueiri TK; Trinh QD
    Urol Oncol; 2018 Mar; 36(3):88.e1-88.e9. PubMed ID: 29277584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
    Kusaka A; Hatakeyama S; Hosogoe S; Hamano I; Iwamura H; Fujita N; Fukushi K; Narita T; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Kawaguchi T; Ohyama C
    Med Oncol; 2017 May; 34(5):90. PubMed ID: 28397105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight Loss Following Radical Cystectomy for Bladder Cancer: Characterization and Effect on Survival.
    McDonald ML; Liss MA; Nseyo UU; Gal DB; Kane CJ; Kader AK
    Clin Genitourin Cancer; 2017 Feb; 15(1):86-92. PubMed ID: 27460433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.
    Koie T; Ohyama C; Yamamoto H; Hatakeyama S; Imai A; Yoneyama T; Hashimoto Y; Kitayam M; Hirota K
    Urol Oncol; 2014 Aug; 32(6):820-5. PubMed ID: 24951323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant ureteroenteric anastomotic stricture following radical cystectomy with urinary diversion: Patterns, risk factors, and outcomes.
    Westerman ME; Parker WP; Viers BR; Rivera ME; Karnes RJ; Frank I; Tarrell R; Thapa P; Thompson RH; Tollefson MK; Boorjian SA
    Urol Oncol; 2016 Nov; 34(11):485.e1-485.e6. PubMed ID: 27423823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
    Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
    Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?
    Kang M; Balpukov UJ; Jeong CW; Kwak C; Kim HH; Ku JH
    Clin Genitourin Cancer; 2017 Jun; 15(3):e411-e420. PubMed ID: 28162942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
    Peng D; Gong YQ; Hao H; He ZS; Li XS; Zhang CJ; Zhou LQ
    BMC Cancer; 2017 Jun; 17(1):391. PubMed ID: 28578683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer.
    Hara T; Matsuyama H; Kamiryo Y; Hayashida S; Yamamoto N; Nasu T; Joko K; Baba Y; Suga A; Yamamoto M; Aoki A; Takai K; Yoshihiro S; Konishi M; Sakano S; Imoto K; Tei Y; Yamaguchi S; Yano S;
    Int J Clin Oncol; 2016 Feb; 21(1):139-47. PubMed ID: 26077140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
    Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Gershman B; Moreira DM; Tollefson MK; Frank I; Cheville JC; Thapa P; Tarrell RF; Thompson RH; Boorjian SA
    Urol Oncol; 2016 Jan; 34(1):4.e1-9. PubMed ID: 26329815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.
    Mayr R; Gierth M; Zeman F; Reiffen M; Seeger P; Wezel F; Pycha A; Comploj E; Bonatti M; Ritter M; van Rhijn BWG; Burger M; Bolenz C; Fritsche HM; Martini T
    J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):505-513. PubMed ID: 29479839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Outcomes and Early Survival in Octogenarians Who Underwent Radical Cystectomy for Bladder Cancer.
    Zattoni F; Palumbo V; Giannarini G; Crestani A; Kungulli A; Novara G; Zattoni F; Ficarra V
    Urol Int; 2018; 100(1):13-17. PubMed ID: 29212084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical cystectomy in the treatment of bladder cancer in Iceland: A population-based study.
    Björnsson O; Gudmundsson EO; Marteinsson VT; Jonsson E
    Scand J Urol; 2016; 50(1):65-70. PubMed ID: 26390011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches.
    Kim TH; Sung HH; Jeon HG; Seo SI; Jeon SS; Lee HM; Choi HY; Jeong BC
    J Endourol; 2016 Jul; 30(7):783-91. PubMed ID: 27055782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative change in neutrophil-lymphocyte ratio predicts the overall survival of patients with bladder cancer undergoing radical cystectomy.
    Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Komai Y; Sugi M; Murota T; Kawa G; Matsuda T
    Jpn J Clin Oncol; 2016 Dec; 46(12):1162-1167. PubMed ID: 27589936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.